NVCR Reports $174M Revenue, $0.62 EPS Loss, +12% YoY, FDA Approves Optune Pax, $432M Cash
NovoCure Limited Ordinary Shares · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $16.56
+19% in 7d after detection
Post-detection moves
1h
—
1d
+9.3%
3d
+4.4%
7d
+19%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS